Departement Endocrinology, University Hospitals Leuven
Leuven, 3000, Belgium
Location status: Recruiting
NCT Number: NCT05713448
A registry of individuals with type 1 diabetes that visited the Department of Endocrinology of the University Hospitals of Leuven is established. The objective of this registry is to phenotype patients with type 1 diabetes and obesity and their response to treatment with regard to their outcomes
Interested in participating?
Request InfoAll sexes
Observational
Leuven, 3000, Belgium
Location status: Recruiting
A registry/database is constructed with data of the individuals with type 1 diabetes that visited the Department of Endocrinology of the University Hospitals of Leuven. Data will be obtained from all visits in terms of sociodemographics, disease origin and disease impact including but not limited to glycemic control, medical history, comorbidities, complications, clinical parameters, anthropometric parameters, biochemical blood values, medical therapy, lifestyle, ...
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
No intervention
Time frame: Up to 100 years
Prevalence of obesity in type 1 diabetes
Contact information is provided by the study sponsor or research team.
Universitaire Ziekenhuizen KU Leuven
Other
Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes and Its Effect on Treatment and Associated Co-morbidities
Acronym: POOT1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05414409
Autoimmune Diseases, Body Weight
Indianapolis, Indiana, United States
View Trial DetailsNCT06914895
Autoimmune Diseases, Body Weight
Santa Barbara, California, United States
View Trial DetailsNCT06134986
Autoimmune Diseases, Body Weight
Chicago, Illinois, United States
View Trial DetailsNCT06962280
Autoimmune Diseases, Body Weight
Bonita, California, United States
View Trial Details